Tsutomu Tabata

19PUBLICATIONS
128CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Major global burdens of diseasePredictive and prognostic markersEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Sep 26, 2026
Guidelines for the treatment of ovarian cancer, fallopian tube cancer, and primary peritoneal cancer: 2025 edition by the Japan Society of Gynecologic Oncology.

|May 21, 2025
Japan Society of Gynecologic Oncology 2023 guidelines for treatment of uterine body neoplasm.

Tohru Morisada, Yoichi Kobayashi, Satoru Nagase

|Apr 04, 2025
Quality indicators for endometrial cancer care in Japan.

Tamaki Kakuwa, Yuichi Ichinose, Ryoko Rikitake

|Sep 09, 2024
Niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer: final results of a multicenter phase 2 study.

Daisuke Aoki, Tsutomu Tabata, Satoshi Yanagida

|Jul 19, 2024
Niraparib as maintenance therapy in Japan: a retrospective observational study using a Japanese claims database.

Takashi Motohashi, Muneaki Shimada, Hideki Tokunaga

|Dec 01, 2023
Japan Society of Gynecologic Oncology 2022 guidelines for uterine cervical neoplasm treatment.

Manabu Seino, Satoru Nagase, Hideki Tokunaga

Pageof 4

Frequent Collaborators

11 joint publications

Yoichi Kobayashi

11 joint publications

Satoru Nagase

9 joint publications

Mikio Mikami

8 joint publications

Masanori Kaneuchi